Drug General Information
Drug ID
D0X7PP
Former ID
DNC014319
Drug Name
ERITADENINE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530323]
Structure
Download
2D MOL

3D MOL

Formula
C9H11N5O4
Canonical SMILES
C1=NC2=C(C(=N1)N)N=CN2CC(C(C(=O)O)O)O
InChI
1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
InChIKey
LIEMBEWXEZJEEZ-INEUFUBQSA-N
PubChem Compound ID
Target and Pathway
Target(s) Adenosylhomocysteinase Target Info Inhibitor [530323]
BioCyc Pathway Superpathway of methionine degradation
Methionine degradation
Cysteine biosynthesis
KEGG Pathway Cysteine and methionine metabolism
Metabolic pathways
PathWhiz Pathway Selenoamino Acid Metabolism
Betaine Metabolism
Methionine Metabolism
WikiPathways Metabolism of amino acids and derivatives
Trans-sulfuration and one carbon metabolism
One Carbon Metabolism
Trans-sulfuration pathway
Phase II conjugation
Folate Metabolism
References
Ref 530323Bioorg Med Chem. 2009 Sep 15;17(18):6707-14. Epub 2009 Jul 28.A new structural class of S-adenosylhomocysteine hydrolase inhibitors.
Ref 530323Bioorg Med Chem. 2009 Sep 15;17(18):6707-14. Epub 2009 Jul 28.A new structural class of S-adenosylhomocysteine hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.